Terms: = Germ cell tumor AND ESR1, ESR, 2099, ENSG00000091831, RP1-130E4_1, NR3A1, ESRA, DKFZp686N23123, ER, Era AND Treatment
36468 results:
1. Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options.
Jara MA
Crit Rev Oncog; 2024; 29(3):83-90. PubMed ID: 38683155
[TBL] [Abstract] [Full Text] [Related]
2. HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments.
Bai J; Zhao Y; Shi K; Fan Y; Ha Y; Chen Y; Luo B; Lu Y; Jie W; Shen Z
J Transl Med; 2024 Apr; 22(1):391. PubMed ID: 38678297
[TBL] [Abstract] [Full Text] [Related]
3. Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma.
Versluis JM; Blankenstein SA; Dimitriadis P; Wilmott JS; Elens R; Blokx WAM; van Houdt W; Menzies AM; Schrage YM; Wouters MWJM; Sanders J; Broeks A; Scolyer RA; Suijkerbuijk KPM; Long GV; Akkooi ACJV; Blank CU
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38677880
[TBL] [Abstract] [Full Text] [Related]
4. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
[TBL] [Abstract] [Full Text] [Related]
5. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
6. Clinical outcomes and challenges of surgical extirpation for carotid body paraganglioma in South Korea: a single-center retrospective study.
Shin J; Yun JS; Kim YW
World J Surg Oncol; 2024 Apr; 22(1):112. PubMed ID: 38664798
[TBL] [Abstract] [Full Text] [Related]
7. A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma.
Michaelsen GL; da Silva LDRE; de Lima DS; Jaeger MDC; Brunetto AT; Dalmolin RJS; Sinigaglia M
J Mol Neurosci; 2024 Apr; 74(2):47. PubMed ID: 38662144
[TBL] [Abstract] [Full Text] [Related]
8. ID1
Choi SH; Jang J; Kim Y; Park CG; Lee SY; Kim H; Kim H
Cell Death Dis; 2024 Apr; 15(4):292. PubMed ID: 38658527
[TBL] [Abstract] [Full Text] [Related]
9. Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.
Tada T; Norton TD; Leibowitz R; Landau NR
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38658032
[TBL] [Abstract] [Full Text] [Related]
10. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract] [Full Text] [Related]
11. RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma.
Jermakowicz AM; Kurimchak AM; Johnson KJ; Bourgain-Guglielmetti F; Kaeppeli S; Affer M; Pradhyumnan H; Suter RK; Walters W; Cepero M; Duncan JS; Ayad NG
Sci Rep; 2024 Apr; 14(1):9284. PubMed ID: 38654040
[TBL] [Abstract] [Full Text] [Related]
12. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
[TBL] [Abstract] [Full Text] [Related]
13. [Therapeutic efficacy analysis of endoscopic combined with serological diagnosis strategy and endoscopic in G1 and G2 gastric neuroendocrine neoplasms].
Li WY; Liu Y; Zhang YM; Dou LZ; He S; Ke Y; Liu XD; Liu YM; Wu HR; Wang GQ
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):326-334. PubMed ID: 38644268
[No Abstract] [Full Text] [Related]
14. Postpartum Breast Cancer and Survival in Women With germline BRCA Pathogenic Variants.
Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
[TBL] [Abstract] [Full Text] [Related]
15. Utilization of sperm cryopreservation in patients with testicular cancer.
Menzel V; Richter E; Helke C; Bürk BT; Erb HHH; Leike S; Borkowetz A; Thomas C; Baunacke M
J Cancer Res Clin Oncol; 2024 Apr; 150(4):201. PubMed ID: 38630148
[TBL] [Abstract] [Full Text] [Related]
16. Skin Cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients.
Åkerla P; Pukkala E; Helminen M; Korhonen N; Karppinen T
Acta Derm Venereol; 2024 Apr; 104():adv39927. PubMed ID: 38629891
[TBL] [Abstract] [Full Text] [Related]
17. Skin cancer occurrence: single-center experiences from period 2020-2022.
Łaziński Ł; Koziej M; Antoszewski B; Fijałkowska M
Pol Przegl Chir; 2023 Oct; 96(2):26-30. PubMed ID: 38629283
[TBL] [Abstract] [Full Text] [Related]
18. Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial.
Li R; Li X; You X; Su M; Liu Y; Ke N; Cao D
Cancer Med; 2024 Apr; 13(8):e7131. PubMed ID: 38629255
[TBL] [Abstract] [Full Text] [Related]
19. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract] [Full Text] [Related]
20. Could the mitotic count improve personalized prognosis in melanoma patients?
Buja A; Rugge M; Cozzolino C; Dossi F; Zorzi M; Vecchiato A; de Luca G; Del Fiore P; Tropea S; dall'Olmo L; Rossi CR; Boccuzzo G; Mocellin S
PLoS One; 2024; 19(4):e0302309. PubMed ID: 38626072
[TBL] [Abstract] [Full Text] [Related]
[Next]
